NCT06735664
- Conditions
- Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome, +1 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Recurrent Transformed Chronic Lymphocytic Leukemia
Explore clinical trials studying Recurrent Transformed Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.
10 public trials
6 recruiting studies
Recurrent Transformed Chronic Lymphocytic Leukemia trial results
NCT05672251
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Recruiting
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
NCT04892277
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT05418088
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
- Locations
-
- Nationwide Children's Hospital Columbus, Ohio, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT05873712
- Conditions
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Recurrent Transformed Non-Hodgkin Lymphoma, +5 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Active, not recruiting
Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
NCT07166419
- Conditions
- Blast Crisis, Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Bone Marrow Diseases, +39 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome
NCT02846623
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03277729
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +43 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
NCT05672173
- Conditions
- Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States